the lancet oncology | Journament

Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Sign In to Calculate Scores Authentication required

the lancet oncology

Login or register to claim ownership or editorship of this journal.
Indexings
scopus ncbi
Short Name lancet oncol
Abbreviated Name lancet oncol
ISSN 1474-5488
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (9 total)

2017
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
Chiappella A;Martelli M;Angelucci E;Brusamolino E;Evangelista A;Carella AM;Stelitano C;Rossi G;Balzarotti M;Merli F;Gaidano G;Pavone V;Rigacci L;Zaja F;D'Arco A;Cascavilla N;Russo E;Castellino A;Gotti M;Congiu AG;Cabras MG;Tucci A;Agostinelli C;Ciccone G;Pileri SA;Vitolo U;;
Vol. 18 , No. 8 , pp. -
400 views Abstract
2019
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Giuliano, Mario;Schettini, Francesco;Rognoni, Carla;Milani, Manuela;Jerusalem, Guy;Bachelot, Thomas;De Laurentiis, Michelino;Thomas, Guglielmo;De Placido, Pietro;Arpino, Grazia;De Placido, Sabino;Cristofanilli, Massimo;Giordano, Antonio;Puglisi, Fabio;Pistilli, Barbara;Prat, Aleix;Del Mastro, Lucia;Venturini, Sergio;Generali, Daniele;
289 views DOI Abstract
2016
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Dimopoulos, Meletios A;Moreau, Philippe;Palumbo, Antonio;Joshua, Douglas;Pour, Ludek;Hájek, Roman;Facon, Thierry;Ludwig, Heinz;Oriol, Albert;Goldschmidt, Hartmut;Rosiñol, Laura;Straub, Jan;Suvorov, Aleksandr;Araujo, Carla;Rimashevskaya, Elena;Pika, Tomas;Gaidano, Gianluca;Weisel, Katja;Goranova-Marinova, Vesselina;Schwarer, Anthony;Minuk, Leonard;Masszi, Tamás;Karamanesht, Ievgenii;Offidani, Massimo;Hungria, Vania;Spencer, Andrew;Orlowski, Robert Z;Gillenwater, Heidi H;Mohamed, Nehal;Feng, Shibao;Chng, Wee-Joo;, ;
Vol. 17 , No. 1 , pp. 27-38
288 views DOI Abstract
2016
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Neal, Joel W;Dahlberg, Suzanne E;Wakelee, Heather A;Aisner, Seena C;Bowden, Michaela;Huang, Ying;Carbone, David P;Gerstner, Gregory J;Lerner, Rachel E;Rubin, Jerome L;Owonikoko, Taofeek K;Stella, Philip J;Steen, Preston D;Khalid, Ahmed Ali;Ramalingam, Suresh S;, ;
Vol. 17 , No. 12 , pp. 1661-1671
252 views DOI Abstract
2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.
Armstrong, Terri S;Dirven, Linda;Arons, David;Bates, Amanda;Chang, Susan M;Coens, Corneel;Espinasse, Claire;Gilbert, Mark R;Jenkinson, David;Kluetz, Paul;Mendoza, Tito;Rubinstein, Larry;Sul, Joohee;Weller, Michael;Wen, Patrick Y;van den Bent, Martin J;Taphoorn, Martin J B;
Vol. 21 , No. 2 , pp. e97-e103
249 views DOI Abstract
2020
Radiotheranostics: a roadmap for future development.
Herrmann, Ken;Schwaiger, Markus;Lewis, Jason S;Solomon, Stephen B;McNeil, Barbara J;Baumann, Michael;Gambhir, Sanjiv S;Hricak, Hedvig;Weissleder, Ralph;
Vol. 21 , No. 3 , pp. e146-e156
215 views DOI Abstract
2013
Is India ready to lead the battle for fair access to medicines?
Lancet Oncology, ;
Vol. 14 , No. 6 , pp. 437
202 views DOI
2019
Erratum: Correction to Lancet Oncol 2019; 20: 408-19 (The Lancet. Oncology (2019) 20 3 (408-419) PII: S1470-2045(19)30587-X)
not, found
Vol. 20 , pp. e559
176 views DOI
2010
Pancreatic cancer: a neglected killer?
Lancet Oncology, ;
Vol. 11 , No. 12 , pp. 1107
169 views DOI
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0
Journament